Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
EF-001 by Everfront Biotech for Anaplastic Astrocytoma: Likelihood of Approval
EF-001 is under clinical development by Everfront Biotech and currently in Phase II for Anaplastic Astrocytoma. According to GlobalData, Phase...
Data Insights
EF-001 by Everfront Biotech for Glioblastoma Multiforme (GBM): Likelihood of Approval
EF-001 is under clinical development by Everfront Biotech and currently in Phase II for Glioblastoma Multiforme (GBM). According to GlobalData,...